Matinas BioPharma Holdings (MTNB) Restructuring Costs (2018 - 2021)
Matinas BioPharma Holdings (MTNB) reported Restructuring Costs of $15000.0 for Q4 2021, down 48.28% year-over-year from $29000.0 in Q4 2020, and down 48.28% quarter-over-quarter from $29000.0 in Q3 2021.
Matinas BioPharma Holdings (MTNB) Restructuring Costs (2018 - 2021) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 4 years of Restructuring Costs data on file, last reported at $15000.0 in Q4 2021.
- Restructuring Costs for Q4 2021 came in at $15000.0, down 48.28% year-over-year; the trailing twelve-month figure through Mar 2022 was $72000.0 (down 68.97% YoY), and the FY2021 annual result was $100000.0, down 65.75% from the prior year.
- Restructuring Costs declined to $15000.0 in Q4 2021 per MTNB's latest filing, from $29000.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $341828.0 in Q2 2018 and troughed at $172.0 in Q1 2018.
- A 4-year average of $90673.3 and a median of $62100.0 in 2019 frame the typical range for Restructuring Costs.
- On a YoY basis, Restructuring Costs climbed as much as 67748.84% in 2019 and fell as far as 82.83% in 2019.
- A 4-year view of Restructuring Costs shows it stood at $274000.0 in 2018, then tumbled by 55.26% to $122600.0 in 2019, then plunged by 76.35% to $29000.0 in 2020, then tumbled by 48.28% to $15000.0 in 2021.
- Business Quant data shows MTNB's Restructuring Costs at $15000.0 in Q4 2021, $29000.0 in Q3 2021, and $28000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 15,000.00 |
| Sep 30, 2021 | 29,000.00 |
| Jun 30, 2021 | 28,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Dec 31, 2020 | 29,000.00 |
| Sep 30, 2020 | 90,000.00 |
| Jun 30, 2020 | 93,000.00 |
| Mar 31, 2020 | 80,000.00 |
| Dec 31, 2019 | 122,600.00 |
| Sep 30, 2019 | 62,100.00 |
| Jun 30, 2019 | 58,700.00 |
| Mar 31, 2019 | 116,700.00 |
| Sep 30, 2018 | 274,000.00 |
| Jun 30, 2018 | 341,828.00 |
| Mar 31, 2018 | 172.00 |